These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38262117)

  • 1. Evaluation of maternal serum VEGF, TNF-alpha, IL-4, and IL-10 levels in differentiating placenta accreta spectrum from isolated placenta previa.
    Farisoğullari N; Tanaçan A; Sakcak B; Denizli R; Baştemur AG; Başaran E; Kara Ö; Yazihan N; Şahin D
    Cytokine; 2024 Apr; 176():156513. PubMed ID: 38262117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of vascular endothelial growth factor and placenta growth factor for placenta accreta spectrum.
    Faraji A; Akbarzadeh-Jahromi M; Bahrami S; Gharamani S; Raeisi Shahraki H; Kasraeian M; Vafaei H; Zare M; Asadi N
    J Obstet Gynaecol; 2022 Jul; 42(5):900-905. PubMed ID: 34558384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].
    Bai GQ; Chen WL; Huang XH; Zhao SJ; Zhao SP; Chen XJ; Chen SW; Yang H; Lu X; Liu GY; Chen QH; Zhang LA; Jin L
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):26-36. PubMed ID: 36720612
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased levels of serum IL-33 is associated with adverse maternal outcomes in placenta previa accreta.
    Ozler S; Oztas E; Guler BG; Caglar AT
    J Matern Fetal Neonatal Med; 2021 Oct; 34(19):3192-3199. PubMed ID: 31608786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammation index to predict placenta accreta spectrum and its histological subtypes.
    Keles A; Dagdeviren G; Yucel Celik O; Karatas Sahin E; Obut M; Cayonu Kahraman N; Celen S
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1675-1682. PubMed ID: 35365935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis.
    Jauniaux E; Bhide A
    Am J Obstet Gynecol; 2017 Jul; 217(1):27-36. PubMed ID: 28268196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of placenta accreta spectrum in patients with placenta previa using a clinical, US and MRI combined model: A retrospective study with external validation.
    Maurea S; Verde F; Romeo V; Stanzione A; Mainenti PP; Raia G; Barbuto L; Iacobellis F; Santangelo F; Sarno L; Migliorini S; Petretta M; D'Armiento M; De Dominicis G; Santangelo C; Guida M; Romano L; Brunetti A
    Eur J Radiol; 2023 Nov; 168():111116. PubMed ID: 37801998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of placenta previa attached to cesarean scar for adverse pregnant outcomes in patients with placenta accreta spectrum disorders].
    Zheng WR; Yang XR; Sun J; Mu Y; Yan J; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Dec; 56(12):861-867. PubMed ID: 34954965
    [No Abstract]   [Full Text] [Related]  

  • 11. Is prophylactic intraoperative abdominal aortic balloon occlusion beneficial in pregnancies with placenta previa and placenta accreta spectrum during cesarean section? A 5-year retrospective study.
    Wang ZX; Zhao YF; Li L
    Int J Gynaecol Obstet; 2023 Nov; 163(2):572-578. PubMed ID: 37183630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing placenta accreta from placenta previa via maternal plasma levels of sFlt-1 and PLGF and the sFlt-1/PLGF ratio.
    Zhang F; Gu M; Chen P; Wan S; Zhou Q; Lu Y; Li L
    Placenta; 2022 Jun; 124():48-54. PubMed ID: 35635854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental thickness correlates with placenta accreta spectrum (PAS) disorder in women with placenta previa.
    Li Y; Choi HH; Goldstein R; Poder L; Jha P
    Abdom Radiol (NY); 2021 Jun; 46(6):2722-2728. PubMed ID: 33388802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa.
    Wang N; Shi D; Li N; Qi H
    Ann Med; 2021 Dec; 53(1):2041-2049. PubMed ID: 34927512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental volume as a novel sign for identifying placenta accreta spectrum in pregnancies with complete placenta previa.
    Yue Y; Wang X; Zhu L; Liu C; Chen D; Lu Y; Liang B
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):52. PubMed ID: 38200440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Placenta Previa With Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder.
    Han X; Guo Z; Yang X; Yang H; Ma J
    JAMA Netw Open; 2022 Aug; 5(8):e2228002. PubMed ID: 35994286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracervical lakes as sonographic marker of placenta accreta spectrum disorder in patients with placenta previa or low-lying placenta.
    di Pasquo E; Ghi T; Calì G; D'Antonio F; Fratelli N; Forlani F; Prefumo F; Kaihura CT; Volpe N; Dall'Asta A; Frusca T
    Ultrasound Obstet Gynecol; 2020 Apr; 55(4):460-466. PubMed ID: 31503353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of serum levels and placental bed tissue expression of IGF-1, bFGF, and PLGF in patients with placenta previa complicated with placenta accreta spectrum disorders.
    Arakaza A; Liu X; Zhu J; Zou L
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2305264. PubMed ID: 38247274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.